follows: Unit: Million Baht Revenue Structure Q3/2019 Q3/2018 Change General Patient Revenue 1,683.8 1,518.9 164.9 10.9% Social Security Scheme Revenue 785.4 709.1 76.3 10.8% Other Revenue 31.3 26.3 5.0
was also increased by 38.5%. The number of both in-patient and out-paient were increased by 20.8%, also, revenue from out-patient and in-patient were increased by 17.5% and 50.9%. Cost of medical
by 22.3%. The number of both in-patient and out-paient were increased by 9.3%. Revenue from out-patient and in-patient were increased by 8.4% and 17.2%. Cost of medical treatments The Cost of medical
financial to Thai Japan Laboratories Co., Ltd. (TJL). 2.Date/Month/Year of Transaction December 3, 2018 3.Financial Aid D.T.C. industries Plc. 4.Financial aid recipients beneficiary details Thai Japan
ข้อตกลงเพื่อขยายความร่วมมือระหว่าง ACMF และ IFRS Foundation (ACMF-IFRS Foundation Dialogue on IFRS Sustainability Disclosure Standards: AID) ในโอกาสนี้ ก.ล.ต. ไทย ได้ร่วมแสดงความยินดีต่อการส่งมอบการเป็น
-patient and out-paient were increased, also, revenue from out-patient tend to increase. By the way, revenue from medical treatment per patient was in inclined. Cost of Hospital Operations The cost of
. However, people still have anxiety about the widespread of COVID-19 which affect the decision in going to the hospital, led to a significant decrease in regular patient traffic compared to the same period
announced to change the mixture from 5% to 7%) 3. Gross profit increased from the declining price of crude palm oil, due to weather conditions that was accommodating oil palm production, which led to an
-patients were Baht 171.18 mllion and 178.81 million respectively, which increased by 4.5%. An increase was primarily due to the increment in average revenue per visit both in-patient and out-patient. Also
bill amount per patient. Operation : Consolidated Profit & Loss Statement 4Q 4Q % 12 mth 12 mth % Unit : THB million 2017 2016 change 2017 2016 change Revenue from non-social security 197.87 182.46 8